GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
10.4484 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, ESR1, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PPARA, PTGS2 |
9.25796 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
9.17778 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PTGS2, TYR, XDH |
8.29712 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FUT7, GBA2, IDO1, PPARA, PTGS2, TYR, XDH |
7.74511 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
7.45052 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
7.33463 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, BCL2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, HSD11B2, HSD17B2, IDO1, PPARA, PTGS2, TYR |
7.10113 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.04098 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
6.96624 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, HSD11B2, HSD17B2, IDO1, PTGS2, TYR |
6.60231 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, HSD11B2, PTGS2, TYR |
6.58933 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
6.25647 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.23795 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, GBA2, TYR |
6.06707 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FUT7, GBA2, HSD17B1, HSD17B2, IDO1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
5.80323 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PPARA, PTGS2, TNKS, TNKS2, XDH |
5.28632 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, HSD11B2, HSD17B2, IDO1, PPARA, PTGS2, TYR |
5.27171 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.19032 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, IDO1 |
5.13639 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
5.08394 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGS2 |
4.98921 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.68229 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FUT7, GBA2, PPARA, PTGS2 |
4.44763 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, AOX1, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PPARA, PTGS2, TYR, XDH |
4.35079 |
[BP] GO:0048513 |
animal organ development
|
ACHE, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, HSD11B1, HSD17B2, PPARA, TYR |
4.31516 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, HSD11B2, PPARA, PTGS2 |
4.315 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, GBA2, HSD11B1, HSD17B2, PPARA, PTGS2, TYR |
4.30471 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
4.22565 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
4.10409 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, HSD11B2, HSD17B2, IDO1, PPARA, PTGS2, TYR |
4.00578 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
3.74513 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, DRD1, DRD2, PTGS2, TNKS, TNKS2 |
3.73766 |
[BP] GO:0032844 |
regulation of homeostatic process
|
BCL2, CA2, CA7, CDK6, DRD1, DRD2, PTGS2, TNKS, TNKS2 |
3.64128 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, TYR |
3.61479 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, HSD11B2, PPARA, PTGS2 |
3.58245 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, PTGS2, PTPN1, TNKS, TNKS2, XDH |
3.51189 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, PTGS2, PTPN1, TNKS, TNKS2, XDH |
3.49492 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.44591 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.39453 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, BCL2, CA2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FUT7, GBA2, HSD11B1, HSD17B2, PPARA, PTGS2, TNKS2, TYR |
3.2536 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
3.20043 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2 |
3.13055 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.1145 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, PPARA |
3.10914 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
3.08518 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
3.02976 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD11B2, HSD17B2, IDO1, PTGS2 |
3.00746 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, IDO1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, XDH |
2.96229 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.92724 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, PTGS2 |
2.8765 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGS2 |
2.8501 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, PTGS2 |
2.84126 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
CA2, CA7, DRD1, DRD2, PTGS2 |
2.81394 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.75457 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, GBA2, IDO1, PPARA, PTGS2 |
2.7483 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.7483 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.68559 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX5, ALPL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F3, HSD11B2, HSD17B2, IDO1, PPARA, PTGS2, TNKS2, TYR |
2.65155 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, DRD1, DRD2, PTGS2 |
2.59668 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.56389 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, ESR1, F3, FUT7, GBA2, IDO1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
2.56389 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.5299 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.5299 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, IDO1 |
2.49693 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.46361 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.41043 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, HSD11B2, PPARA, PTGS2 |
2.40526 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, PPARA |
2.40526 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
2.37578 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, HSD11B2, PPARA, PTGS2 |
2.34186 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2 |
2.33994 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, DRD2, HSD11B2, PTGS2 |
2.33682 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.33669 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, GBA2 |
2.33669 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.33669 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DRD2, ESR1, ESRRA, F3, IDO1, PTGS2, XDH |
2.31077 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.31077 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.31077 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.31077 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, PTGS2, TYR |
2.28362 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.28362 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.2831 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.23977 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, HSD11B2, PPARA, PTGS2 |
2.20338 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.20338 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.20338 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, PTGS2 |
2.19499 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, CYP3A4, IDO1, PTGS2 |
2.17737 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PPARA, PTGS2 |
2.17737 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.17442 |
[BP] GO:0009611 |
response to wounding
|
ACHE, BCL2, CYP1A1, DRD2, PPARA |
2.17291 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, CA2, CA7, DRD1, DRD2, PTGS2 |
2.16099 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, CA2, CA7, DRD1, DRD2, PTGS2 |
2.16099 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, BCL2, CA2, CYP1A1, DRD1, DRD2, HSD11B2, PPARA, PTGS2, TYR |
2.16099 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, DRD2 |
2.16099 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.16099 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.16099 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.16099 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.16099 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, IDO1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, XDH |
2.13075 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP3A4, IDO1, XDH |
2.12956 |
[BP] GO:0003014 |
None
|
AKR1B1, BCL2, DRD2, HSD11B2 |
2.09109 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, PTGS2 |
2.04903 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGS2 |
2.02758 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.02553 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.02553 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.02553 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.02553 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.02553 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.02553 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1 |
2.01917 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGS2 |
3.85582 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGS2, PTPN1 |
3.20043 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
2.80192 |
[CC] GO:0031090 |
None
|
ALOX5, BCL2, CA4, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, FUT7, GBA2, PTGS2, TNKS, TNKS2, TYR |
1.45461 |
[CC] GO:0044422 |
organelle part
|
AKR1B1, ALOX5, AOX1, BCL2, CA4, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, IDO1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, TYR |
1.33337 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, PPARA, PTPN1, TNKS, TYR, XDH |
10.8769 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PTGS2, TYR, XDH |
9.38107 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.88506 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
7.32252 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, IDO1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
6.96624 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
6.25647 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, HSD17B1, IDO1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
6.2194 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
6.19624 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.94819 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
5.82257 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.80323 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.7261 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B2, HSD17B1, IDO1, PTGS2, XDH |
5.46781 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, IDO1, PTGS2 |
5.15602 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.0881 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, IDO1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
5.06421 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, IDO1, PTGS2 |
4.99018 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS2, TYR |
4.67429 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.64648 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
4.55631 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.48588 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.48588 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, PPARA, PTPN1, TNKS |
4.35079 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
4.30471 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.1528 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.08644 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.9113 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.79599 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.58085 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
3.14026 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
3.1145 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.92724 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.92724 |
[MF] GO:0008289 |
lipid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F3, HSD11B2, HSD17B1, PPARA |
2.57112 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.5299 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.33669 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX5, IDO1, PTGS2 |
2.31077 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.31077 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.31077 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.31077 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.16099 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.16099 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP3A4 |
2.09529 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.02553 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.02553 |